4.3 How do we measure our economic impact?

We have done initial evaluations of the economic impact of our platform in several ways, primarily through post-assessment evaluation, independent third-party research validation, and user feedback. Specifically, we work with our health system, provider, and payer partners to aggregate Ada’s triage recommendations against the actual treatment sought and delivered. Such analysis is done on an aggregated, de-identified and, anonymized basis. Thus far, in the initial evaluations, research conducted in a primary care setting in the UK suggests that after using Ada, 13% of patients would have chosen a different care option (self-care at home, visiting a pharmacy, delaying their doctor's appointment) rather than consulting with a physician that day. A 13% reduction in the use of primary care services has the potential to yield significant economic benefit and savings opportunities to employers deploying the Ada platform. In addition, properly directing employees to urgent or emergency care when it is needed provides significant savings, better outcomes, less stress on the overall healthcare system, and more satisfied employees and their dependents.

Sutter Health in the US identified that Ada helped redirect 40% of users to less urgent care, potentially reducing unnecessary pressure on ED, with 47% of Sutter’s Ada assessments completed outside of clinic hours. We continue to undertake research to prove the economic benefits of Ada’s solutions.

We also have evidence that Ada may help identify rare diseases much faster than conventional medical consultations. In a multi-year study conducted with Hannover Medical School, 100 rare disease cases were analyzed retrospectively. Ada was found to correctly diagnose a rare disease in less time than the doctors in nearly two thirds of the cases. This ability to identify rare diseases earlier can lead to earlier treatment and therefore higher levels of productivity and lower absenteeism among affected employees.